HIGHLIGHTS
- who: Thyroid carcinoma and collaborators from the Instituto Nacional do Câncer Universidade Federal do Paraná have published the article: original article, in the Journal: (JOURNAL)
- what: The study shows that in low and intermediate-risk patients RRA with 30 mCi seems to have no major advantage over patients who did not undergo RRA regarding response to initial therapy in each risk group and also in long term outcomes. It should be noted that this work has some limitations.
- how: For comparing medians nonparametric Mann-Whitney test was used and for categories the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.